Skip to main content
. 2017 Apr-Jun;16(2):133–139. doi: 10.4103/1450-1147.203071

Table 3.

Comparing sensitivity of 18F-fluorodeoxyglucose and 18F-fluoroestradiol for only suspected nonhepatic disease lesions

graphic file with name WJNM-16-133-g003.jpg